Leukaemia & Lymphoma Ni

Leukaemia & Lymphoma NI is Northern Ireland's sole charity dedicated to funding research into blood cancers including leukaemia, lymphoma, myeloma, and haematological malignancies, driven by a founding mission to advance innovative scientific and clinical research for superior treatments, higher survival rates, and enhanced quality of life. Core values emphasize research excellence, local investment with 100% of funds supporting Northern Ireland experts, clinician-scientist partnerships, early-career development, and public awareness to drive early diagnosis and intervention. Their theory of change posits that translational research bridging laboratory discoveries to clinical outcomes yields cures, prevents progression, and empowers patients through evidence-based innovation.

They prioritize laboratory-based research projects advancing novel therapies for blood cancer patients, translational science accelerating bench-to-bedside breakthroughs, infrastructure enhancing haematology research capabilities, equipment enabling cutting-edge experiments, research fellowships nurturing clinician-scientists, studentships training medical students in blood cancer investigation, and clinical support roles including blood cancer patient supporters providing emotional guidance and clinical trials nurses facilitating trial access and monitoring. Funding targets interventions improving early detection, treatment efficacy, and patient-centred care for individuals with leukaemia, lymphoma, myeloma facing diagnosis uncertainty, treatment toxicity, relapse risks, or end-stage needs, alongside families enduring caregiving burdens, clinicians delivering specialized haematology services, and students gaining hands-on research skills. Supported activities encompass multi-year projects fostering global knowledge-sharing while prioritizing local impact through partnerships like the Patrick G Johnston Centre for Cancer Research, emphasizing preventative diagnostics, precision medicine, and holistic outcomes from survival to wellbeing.

Exclusions encompass non-blood cancer conditions, research outside Northern Ireland, non-research activities like general healthcare or advocacy without scientific ties, and organizations lacking local research-active ties. Distinctive as the region's only blood cancer research specialist, they uniquely demand 100% local reinvestment, AMRC-aligned ethical standards including animal welfare, and preference for academic-hospital collaborations delivering measurable translational impact for Northern Ireland's blood cancer patients, families, and researchers over broader or non-local efforts.